Home > Back to Publisher > Report Information

Impact of Nano Materials in Drug Delivery & Human Tissue Engineering

Drug and Market Development Publishing
October 1, 2006
195 Pages - SKU: DSMD1354029

Abstract Table of Contents Search inside this report Related Reports

D&MD’s new market analysis report - Impact of Nano Materials in Drug Delivery & Human Tissue Engineering - provides a market driven top down approach that identifies existing products using nano based knowledge to strengthen their capabilities and provides a description of the product’s market niche to pinpoint future trends. A recent analysis of more than 200 commercially available products that use nano-based technological enhancements in the pharmaceutical, medical or healthcare field is reinforcing the notion that “incremental” modifications of existing drugs, drug delivery devices and tissue engineering products enhanced by nano innovations is beginning to harvest revenue.

About the Author

Gautam Thor received his PhD in Neurobiology in 1983 from The Tata Institute of Fundamental Research, India where he got interested in the study of the growth of the visual system that has resulted in the recent formation of Coded Imagery to commercialize some aspects of these studies. He has also researched at UCSD in the field of Neuroimmunology and is the author of numerous scientific and medical publications through NeuroConsultants, and, is internationally recognized for his expertise in human diagnostics.

Chapter 1: Executive Summary
Chapter 2: Nanomaterials Relating to the Drug Discovery, Drug Delivery & Tissue Engineering Industries: Nanoparticles; New MRI Nanomaterials as Probes for Imaging Agents—Gadolinium in Fullerenes & Quantum Dots; Drug Delivery and Therapeutics—Bioavailability through Nanocrystals; Nano Biosensors; Nano Tissue Engineering—Nanophase Biomaterials; Nanochemicals Against Cancer; Nanobiotechnology’s Contributions to the Pharmaceutical/Medical Sectors
Chapter 3: Commercial Pharmaceutical & Tissue Engineering Product Applications Using Nano Materials: Nano Technology and the Pharmaceutical/Tissue Engineering Product Applications Market in 2005; Nanoengineering and Emerging Nanotechnology; Medical & Healthcare Diagnostic Devices Markets; Nanobiotechnology Utility in the Drug Discovery and Delivery Process; Medical & Tissue Engineering Nano Material-based Products in 2005; Future Markets of Pharmaceutical and Medical “Nano Material-based” Products
Chapter 4: Health, Environmental, and Societal Impacts of Nanoparticles: Free Nanoparticles; Regulatory Issues of Nanotechnology; Future Considerations; Social Science Issues
Chapter 5: Global Investments by Private and Federal Resources: Private Funding Accounts for Almost 40-50 % of Investment in the Nanotechnology Sector; Global Distribution of Funding Sources of Nanotechnology; Private Venture Capital Funding in the US Market; Similarities between Nanotechnology, Semiconductor Industry, and DNA Technologies; Patents as Indicators of the Maturity of Nanotech Investments; World Leaders in Nano Investment—US, Japan, EU & China; Nanotechnology Global Investment was Approximately $9 Billion in 2005
Chapter 6: Nanobiotechnology Companies: Nano Material Manufacturing Companies to Watch; List of Nanobiotechnological Companies
Chapter 7: Company Profiles
TABLE OF EXHIBITS: Exhibit 2.1. A Dendrimer Nanoparticle Complex; Exhibit 2.2. Structure of a.Carbon Nanotube; Exhibit 2.3. PCR of a.Biobarcode Assay with Nanoparticles; Exhibit 2.4. A Drug Carrying Liposome; Exhibit 2.5. A Model of the C60 Buckministerfullerene; Exhibit 2.6. Boron-doped Silicon Nanowire; Exhibit 2.7. Nanotech Applications in the Fight Against Cancer; Exhibit 2.8. Nanotechnology Tools and Platforms that Affect the Pharmaceutical & . Medical Industries; Exhibit 3.1. Nano-enhanced Pharmaceutical Nano Products; Exhibit 3.2. Medical/Tissue Engineering Nano Products in 2005; Exhibit 3.3. Nanotechnology Application Markets; Exhibit 3.4. 2005 Nanoparticle Based Products; Exhibit 3.5 Number of Nanomaterial Companies; Exhibit 3.6. Nanomaterials and Nano Tool Market Forecast; Exhibit 3.7. Reporter Molecules and Molecular Tags for Biomolecular Detection; Exhibit 3.8. Biosensor-based Devices; Exhibit 3.9. MRI and PAT Contrast and Imaging Agents; Exhibit 3.10 The Pharmaceutical Drug Discovery Process; Exhibit 3.11 Examples of Nano-enhanced Drug Discovery and Delivery Platforms; Exhibit 3.12. Improved Formulations of Approved Drugs; Exhibit 3.13 Nano-based Drug Delivery Platforms; Exhibit 3.14 Controlled Release Options; Exhibit 3.15 Multifunctional Drug Delivery Applications; Exhibit 3.16 Targeted Drug Delivery Platforms; Exhibit 3.17 Devices for Targeted Drug Delivery; Exhibit 3.18 Tissue Engineering Applications; Exhibit 3.19 Wound Dressings and Wound Repair; Exhibit 3.20 Stents and Catheters; Exhibit 3.21 Dental and Prosthetic Implants; Exhibit 3.22 Current Clinical Trials using Nano Material based Chemistries; Exhibit 3.23 NNI Evaluation of Nanosector Markets; Exhibit 4.1. Dimensions of Biological Molecules in the Nanometer Range; Exhibit 5.1. The Global Nanotechnology Market; Exhibit 5.2. Global Venture Capital Investment into Nanobiotechnology; Exhibit 5.3. VC and Government funding for Japan, USA and EU in Terms of Numbers of Players; Exhibit 5.4. Number of Nanotech Related Patents; Exhibit 5.5. Publications in ISI Web of Science Databases; Exhibit 5.6. Global Government Funding of Nanotechnology; Exhibit 5.7. US 2006 Budget of Nanotechnology Segments; Exhibit 6.1. Companies Leading the Field in Arrays and Molecular Tags; Exhibit 6.2. List of Nanotech Companies

Impact of Nano Materials in Drug Delivery & Human Tissue Engineering

Share this report

Other tasks

Research Assistance

Related Markets

Drug Delivery Reports

Free Alert Me service